top of page
Stack of Magazines

Publications

  • Conniot J#, Scomparin A#, Yeini E, Zupančič E, Peres C, Viana AS, Schwartz H, Erez N, Jung S, Satchi-Fainaro R*, Florindo HF*. Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators. Nature Nanotechnology 2019 ;14(9):891-901.   [ PUBMED ]
     

  • Florindo  HF, Kleiner R, Vaskovich-Koubi D, Acúrcio RC, Carreira B, Yeini Y, Tiram G, Liubomirski Y, Satchi-Fainaro R. Immune-mediated approaches against COVID-19. Nature Nanotechnology, 2020 Jul 13:1-16.
    ​    [ PUBMED ]
     

  • Florindo HF, Madi A, Satchi-Fainaro R. Challenges in the implementation of MIRIBEL criteria on nanobiomed manuscripts. Nature Nanotechnology 2019 ;14:627-628. ​[ PUBMED ]
     

  • Matos AI, Carreira B, Peres C, Moura LIF, Conniot J, Fourniols T, Scomparin A, Martínez-Barriocanal Á, Arango D, Conde JP, Préat V, Satchi-Fainaro R*, Florindo HF*. Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer. Journal of Controlled Release 2019; 10(307):108-138. ​ [ PUBMED ]
     

  • Carreira B, Acúrcio RC, Matos AI, Peres C, Pozzi S, Vaskovich-Koubi D, Kleiner R, Bento M, Satchi-Fainaro R*, Florindo HF*. Nanomedicines as Multifunctional Modulators of Melanoma Immune Microenvironment. Advanced Therapeutics 2020; 2000147.​ [ PUBMED ]
     

  • Silva AL, Peres C, Conniot J, Matos AI, Moura L, Carreira B, Sainz V, Scomparin A, Satchi-Fainaro R, Préat V, Florindo HF. Nanoparticle impact on innate immune cell pattern-recognition receptors and inflammasomes activation. Seminars in Immunology 2017; 34:3-24.​ [ PUBMED ]
     

  • Peres C, Matos AI, Moura LIF, Acúrcio RC, Carreira B, Pozzi S, Vaskovich-Koubi D, Kleiner R, Satchi-Fainaro R*, Florindo HF*, Preclinical models and technologies to advance nanovaccine development, Advanced Drug Delivery Reviews, 172:148-182 (2021). *Corresponding authors. ​[ PUBMED ]
     

  • Matos AI, Peres C, Carreira B, Moura L, Acúrcio R, Coelho R, Vogel T, Wegener E, Ribeiro F, Afonso M, Martínez-Barriocanal A, Arango D, Viana AS, Rodrigues C, Graça L, Jordan R, Satchi-Fainaro R*, Florindo HF*, Polyoxazoline-based nanovaccine and tumor-associated macrophage targeting sensitize colorectal cancer to anti-PD-1 immunotherapy, Advanced Science, 2300299 (2023). *Corresponding authors. ​[ PUBMED ]
     

  • Peres C, Matos AI, Moura LIF, Carreira B, Verdial M, Conniot J, Afonso MB, Acúrcio R, Basto AP, Mensurado S, Silva-Santos B, Santos SCR, Viana AS, Silva LS, Rodrigues CMP, Préat V, Graça L, Madi A, Satchi-Fainaro R*, Florindo HF*. Multifunctional nanovaccine sensitizes triple-negative breast cancer to immune checkpoint therapy, Advanced Functional Materials, in press (2024). *Corresponding authors.​ [ PUBMED ]
     

bottom of page